Associate Professor, Emergency Medicine, University of Michigan Medical School
Emergency Medicine
Dr. Phillip A. Scott, MD
|
|
Give Review
Phillip Scott practices Emergency Medicine. He graduated from University of Louisville School of Medicine. University of Louisville School of Medicine is ranked 83/0 in Research/PrimaryCare. Phillip A. Scott is a published doctor as well. He has 37 publications published. The latest was: Prevention of emergency physician migratory contamination in a cluster randomized trial to increase tissue plasminogen activator use in stroke (the INSTINCT trial). Phillip Scott accepts Medicare.
Publications
- Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology.
- Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.
- Prevention of emergency physician migratory contamination in a cluster randomized trial to increase tissue plasminogen activator use in stroke (the INSTINCT trial).
- Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke-Enhanced Regimen Stroke Trial.
- Review, Historical Context, and Clarifications of the NINDS rt-PA Stroke Trials Exclusion Criteria: Part 1: Rapidly Improving Stroke Symptoms.
- Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american strok...
- The impact of emergency physician turnover on planning for prospective clinical trials.
- A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial.
- Does Preexisting Antiplatelet Treatment Influence Postthrombolysis Intracranial Hemorrhage in Community-treated Ischemic Stroke Patients? An Observational Study.
- An Emergency Department Intervention to Increase Warfarin Use for Atrial Fibrillation.
- Antihypertensive Treatment Prolongs Tissue Plasminogen Activator Door-to-Treatment Time: Secondary Analysis of the INSTINCT Trial.
- National Trends in Use of Computed Tomography in the Emergency Department.
- Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams.
- Lack of association between pretreatment neurology consultation and subsequent protocol deviation in tissue plasminogen activator-treated patients with stroke.
- Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment ...
- Enhancing community delivery of tissue plasminogen activator in stroke through community-academic collaborative clinical knowledge translation.
- Qualitative data collection and analysis methods: the INSTINCT trial.
- Recovery of cognitive function after surgery for aneurysmal subarachnoid hemorrhage.
- Determining intravenous rt-PA eligibility in the Emergency Department.
- For rich and poor, the message is still "dial 9-1-1": but is it getting through?
- Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States.
- Thrombolysis for acute stroke: the incontrovertible, the controvertible, and the uncertain.
- Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes.
- Cost-effectiveness of helicopter transport of stroke patients for thrombolysis.
- Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients.
- Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study.
- The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
- Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinica...
- Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator.
- Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the EC...
- Resource utilization and outcome at a university versus a community teaching hospital in tPA treated stroke patients: a retrospective cohort study.
- Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population.
- Management of acute ischemic stroke.
- Irish nurses'' and midwives'' understanding and experiences of empowerment.
- Perceptions of privacy in the care of elderly people in five European countries.
- Perceptions of informed consent in the care of elderly people in five European countries.
Schools
University Of Louisville
University Hospital
Doctors Specialties
- Emergency Medicine
Accepted Insurances
Education
-
University Hospital - University of Cincinnati College of Medicine -
University of Louisville School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1003991076 | |
| NPPES Provider LastName | SCOTT | |
| NPPES Provider FirstName | PHILLIP | |
| NPPES Provider ZIPCode | 481095301 | |
| NPPES Provider State | MI | |
| Specialty Description | Emergency Medicine | |
| Total Claim Count | 23.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003991076 |
| Last Name Of The Provider | SCOTT |
| First Name Of The Provider | PHILLIP |
| View All |
Similar Doctors
|
|
Dr. Jason J. Ham, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michaelina R. Bolton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kent W. Collin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eduardo J. Navarrete, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristin M. Berg, MD |
|
|
Dr. Kevin R. Ward, MD
This Doctor is OpenDoctor Recommended.
|